Clinical Trials
Recent Trials
Virtual Rehabilitation for Cancer Survivors
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
A Study of Revaree Plus in People With Breast Cancer
Research Evidence
Peer-reviewed studies linked via MeSH term "Breast Carcinoma In Situ" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 189336000
- UMLS CUI
- C0154084
- Fully Specified Name
- Carcinoma in situ of breast (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Clinical Trials
- 7
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.